C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/1989
11/02/1989	EP0339483A2 Renin inhbiting amino-acid derivatives
11/02/1989	EP0339377A2 Modified protein for carrying hapten
11/02/1989	EP0339264A1 Compounds for the introduction of a mercapto group to tyrosin
11/02/1989	EP0339217A2 Specific peptide bond cleavage by organic tertiary phosphines with nucleophilic side chains
11/02/1989	EP0339193A1 Peptide ligands for bombesin receptors
11/01/1989	CN1036795A 肽衍生物 Peptide derivatives
10/1989
10/31/1989	US4877868 Radionuclide antibody coupling
10/31/1989	US4877830 Chromatography of proteins
10/31/1989	US4877614 Biologically active fragments of human antihemophilic factor and method for preparation thereof
10/31/1989	US4877510 Apparatus for preparative gel electrophoresis
10/25/1989	EP0338846A2 Monoclonal antibodies
10/25/1989	EP0338745A1 Method for producing recombinant DNA proteins
10/25/1989	EP0338620A1 Recovery of hepatitis B surface antigen
10/25/1989	EP0338566A2 Pertussis toxoid vaccine
10/25/1989	EP0338436A2 Monoclonal antibody against neuropeptide Y, method for its preparation as well as its use
10/25/1989	EP0338265A2 Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine
10/25/1989	EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2?
10/25/1989	CN1036580A Process for separating alpha-l-aspartyl-l-methyl phenylalaninate
10/24/1989	US4876194 Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
10/24/1989	US4876081 Coupling to proteins, polypeptids; diagnostic and therapy compounds
10/19/1989	WO1989009829A2 Methods of generating desired amino-terminal residues in proteins
10/19/1989	WO1989009825A1 Method for producing recombinant dna proteins
10/19/1989	WO1989009819A1 Combining mutations for stabilization of subtilisin
10/19/1989	WO1989009818A1 Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides
10/19/1989	WO1989009790A1 Monoclonal antibody to enteroviruses
10/19/1989	WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them
10/19/1989	WO1989009787A2 Osteogenic devices
10/19/1989	WO1989009786A1 Peptide derivatives
10/19/1989	WO1989009783A1 Polypeptides stabilized by covalent hydrogen bond replacements
10/19/1989	WO1989009611A1 Cyclic analogs of atrial natriuretic peptides
10/19/1989	WO1989009605A1 Bone-inducing protein
10/19/1989	WO1989009227A3 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
10/19/1989	DE3910667A1 Peptide derivatives
10/19/1989	DE3910323A1 Biologically active proteins
10/18/1989	EP0337731A2 Peptide antibiotics
10/18/1989	EP0337589A2 Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
10/18/1989	EP0337359A2 Lymphokine production and purification
10/18/1989	EP0337334A2 Renin-inhibiting amino acid derivatives
10/18/1989	EP0337243A1 Process for purifying recombinant human interleukin-2
10/18/1989	EP0337203A2 Aglycons of A/16686 antibiotics
10/18/1989	EP0195817B1 Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
10/17/1989	US4874507 Separating constituents of a mixture of particles
10/17/1989	US4874490 Pre-cast gel systems for two-dimensional electrophoresis
10/17/1989	CA1262400A1 Process for the manufacture of glucosamine derivatives
10/11/1989	EP0336779A2 Polypeptides stabilized by covalent hydrogen bond replacements
10/11/1989	EP0336760A2 Bone-inducing protein
10/11/1989	EP0336736A1 Purification of pertussis toxins and production of vaccine
10/11/1989	EP0336441A2 Anti-CPBII monoclonal antibody
10/11/1989	EP0336405A2 Anti-human cancer protein complexes, their production and use
10/11/1989	EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity
10/11/1989	EP0336368A2 N2-(1-carboxy-3-phenylpropyl)-L-lysine derivative and process of producing lysinopril using the compound
10/11/1989	EP0336324A1 Process for treating insoluble fused heterogenic protein
10/11/1989	EP0336230A2 Cyclic peptide antagonists of Substance P and Substance K
10/11/1989	EP0336155A1 Recombinant human cardiac myosin
10/11/1989	EP0335900A1 Human interleukin-4 muteins
10/10/1989	US4873317 Method of separating or purifying proteins and other biopolymers
10/10/1989	US4873312 Unfolding in denaturing solution; diafiltration
10/10/1989	US4873222 Placenta-derived anticoagulating substance
10/10/1989	US4873221 Difluoro peptide compounds
10/05/1989	WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
10/05/1989	WO1989009226A1 Peptides
10/05/1989	WO1989009220A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
10/05/1989	WO1989009092A1 Separating constituents of a mixture of particles
10/05/1989	WO1989009088A1 Paralog affinity chromatography
10/04/1989	EP0335662A1 Peptides
10/04/1989	EP0335423A2 Modified human G-CSF
10/03/1989	US4871670 Dna transfer vector
10/03/1989	US4871663 Exporession vector for human TnF
10/03/1989	CA1262121A1 High performance liquid chromatography mobile phase
09/1989
09/26/1989	US4870163 Purification by multistage adsorption
09/26/1989	US4870055 Segmented polypeptide bioelastomers to modulate elastic modulus
09/26/1989	US4870016 Changing solubility of enzymes
09/26/1989	EP0329693A4 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same.
09/26/1989	CA1262015A1 Acylated sugar derivatives, processes for their manufacture, and their use
09/26/1989	CA1261549A1 Polypeptide cartilage-inducing factors found in bone
09/26/1989	CA1261548A1 Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
09/26/1989	CA1261547A1 Peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same
09/26/1989	CA1260827A1 Antibody-metal ion complexes
09/21/1989	WO1989008845A1 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours
09/21/1989	WO1989008835A1 Thioacylation peptide sequencing with acylation of thiazolines
09/21/1989	WO1989008830A1 Thioacylation peptide sequencing with alcoholysis of thiazolinones
09/21/1989	WO1989008667A1 Recombinant igf binding protein (ibp-1)
09/21/1989	WO1989008666A1 Heparin-binding proteins, dna cuding for them, processes for producing them as well as therapeutic preparations containing them
09/21/1989	WO1989008662A1 General cancer-associated scm-recognition factor, preparation and method of use
09/21/1989	WO1989008661A1 Human heat shock factor
09/21/1989	WO1989008659A1 Organic synthesis employing supercritical carbon dioxide as a reaction solvent
09/21/1989	WO1989008643A1 Urethane-protected amino acid-n-carboxyanhydrides
09/21/1989	DE3807594A1 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren Antibodies, methods for their manufacture, oligosaccharide haptens and clones for production of antibodies and use of antibodies for diagnosis and therapy of tumors
09/20/1989	EP0333691A2 A recombinant fusion protein, its use and a recombinant vector
09/20/1989	EP0333587A2 Method for purifying and isolating carboxyl-terminal peptides
09/20/1989	EP0333574A2 Human nerve growth factor
09/20/1989	EP0333474A2 Process for the selective removal of endotoxin
09/20/1989	EP0333438A2 Novel derivative of human growth hormone
09/20/1989	EP0333201A2 Human heat shock factor
09/20/1989	EP0333174A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same
09/20/1989	EP0333036A2 Separation method of alpha-L-aspartyl-L-phenylalanine methyl ester
09/20/1989	EP0333000A2 Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
09/20/1989	EP0332999A2 Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
09/20/1989	EP0332985A2 Method of purification of factor XII by affinity chromatography
09/20/1989	EP0332659A1 Immunogenic glycopeptides of human cytomegalovirus

1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 518